(Q33983758)

English

Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Complete and prolonged suppression of symptoms and consequences of alcohol-dependence using high-dose baclofen: a self-case report of a physician (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

author name string

Olivier Ameisen

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

13 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Alcohol and Alcoholism

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

40

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

147-150

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Rapid suppression of alcohol withdrawal syndrome by baclofen.

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Role of gamma-aminobutyric acid in antipanic drug efficacy

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Baclofen suppresses motivation to consume alcohol in rats

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Antispasticity drugs: mechanisms of action

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Evidence for addiction-like behavior in the rat.

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Baclofen treatment for chronic posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Baclofen antagonizes intravenous self-administration of nicotine in mice and rats

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Preclinical and clinical studies on naltrexone: what have they taught each other?

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

A pilot trial of topiramate for the treatment of cocaine dependence

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Naltrexone depot for treatment of alcohol dependence: a multicenter, randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Baclofen administration for the treatment of affective disorders in alcoholic patients

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

The Definition of Alcoholism

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Evidence of tolerance to baclofen in treatment of severe spasticity with intrathecal baclofen

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Baclofen suppression of cocaine self-administration: demonstration using a discrete trials procedure.

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

High-dose oral baclofen: experience in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

GABAergic dysfunction in mood disorders

1 reference

https://api.crossref.org/works/10.1093%2FALCALC%2FAGH130

21 January 2018

Identifiers

10.1093/ALCALC/AGH130

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33983758&oldid=1980735510"